Michael Brandt Steketee

Title: **The Innovative Contributions of Michael Brandt Steketee**

Introduction

Michael Brandt Steketee, an accomplished inventor based in Wexford, Pennsylvania, has made significant strides in the field of ocular therapies and local drug delivery. With a total of two patents to his name, he is dedicated to advancing medical treatments that enhance patient care and outcomes.

Latest Patents

Steketee's latest patents showcase his innovative approach to medicine. The first patent, titled "Ocular applications of matrix bound vesicles (MBVs)," discloses methods aimed at increasing retinal ganglion cell survival in individuals in need. This invention involves selecting subjects requiring intervention and administering a therapeutically effective amount of isolated nanovesicles derived from an extracellular matrix.

The second patent focuses on "Devices and methods for local delivery of tacrolimus." This invention features devices built with a polymeric matrix containing tacrolimus or its derivatives that allow for delayed and extended release. These devices can effectively deliver tacrolimus to injured nervous system tissue when implanted, providing a new avenue for treatment.

Career Highlights

Throughout his career, Michael Brandt Steketee has worked with prestigious institutions, including the University of Pittsburgh and the United States of America as represented by the Department of Veterans Affairs. His work at these institutions has enhanced his knowledge and contributed to significant advancements in his field.

Collaborations

Steketee has collaborated with notable professionals such as Yolandi Van der Merwe and Kia M Washington, who have joined him in exploring innovative medical solutions. These collaborations have fostered a dynamic research environment and have contributed to the development of his groundbreaking inventions.

Conclusion

In summary, Michael Brandt Steketee’s contributions to the field of medicine through his two patents demonstrate his commitment to innovation. His work on ocular therapies and local drug delivery devices highlights the potential impact of technological advancements on patient care. As he continues to advance his research, the medical community eagerly anticipates the outcomes of his innovative approaches.